Noninvasive in vivo cell imaging technology
Development of cell therapies such as CAR-T and stem cells, would greatly benefit from the ability to non-invasively track and quantify cells infused into patients. The goal of this EU-funded project is to develop imaging beads for contrast enhancement (BEACONs) to label cell therapies ex vivo and measure biodistribution in vivo using non-invasive imaging technologies for use both preclinically and clinically. Recent advances in the field of cell therapies such as CAR-T and stem cell therapies coupled with the need for biodistribution data and greater safety during clinical trials create attractive markets for such cell tracking technology. Cenya is working with regulatory advisers to define a development plan and obtain broad regulatory approval of BEACONs for use with any type of cell therapy in humans.
Fields of science
Funding SchemeERC-POC-LS - ERC Proof of Concept Lump Sum Pilot
See on map
The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.